We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+6.4%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$301B
AUM Growth
+$5.54B
Cap. Flow
-$7B
Cap. Flow %
-2.32%
Top 10 Hldgs %
14.22%
Holding
9,997
New
1,505
Increased
3,920
Reduced
3,391
Closed
881

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$937M
2
UBS icon
UBS Group
UBS
+$511M
3
MSFT icon
Microsoft
MSFT
+$402M
4
BIDU icon
Baidu
BIDU
+$338M
5
AAPL icon
Apple
AAPL
+$331M

Sector Composition

Rank Sector Weight
1 Technology 11.08%
2 Consumer Discretionary 6.75%
3 Financials 6.3%
4 Healthcare 5.83%
5 Industrials 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MORF
6726
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$42K ﹤0.01%
669
-2,202
-77% -$101K
NMTR
6727
DELISTED
9 Meters Biopharma
NMTR
$42K ﹤0.01%
1,776
-1,978
-53% -$60.8K
NYMX
6728
DELISTED
Nymox Pharmaceutical Corp
NYMX
$42K ﹤0.01%
19,086
+7,579
+66% +$20K
ISEM
6729
DELISTED
Invesco Exchange-Traded Self-Indexed Fund Trust Invesco RAFI Strategic Emerging Markets ETF
ISEM
$42K ﹤0.01%
1,473
+216
+17% +$6.26K
IMPX
6730
DELISTED
AEA-Bridges Impact Corp
IMPX
$42K ﹤0.01%
4,238
+3,264
+335% +$34.2K
DIVA
6731
DELISTED
AGFiQ Hedged Dividend Income Fund
DIVA
$42K ﹤0.01%
1,759
+969
+123% +$22K
SBM
6732
DELISTED
ProShares Short Basic Materials
SBM
$42K ﹤0.01%
759
+466
+159% +$27.2K
CID
6733
DELISTED
VictoryShares International High Div Volatility Wtd ETF
CID
$42K ﹤0.01%
1,315
+56
+4% +$1.74K
ELA icon
6734
Envela
ELA
$468M
$41K ﹤0.01%
8,269
+2,166
+35% +$12.4K
FLSP icon
6735
Franklin Systematic Style Premia ETF
FLSP
$1.04B
$41K ﹤0.01%
2,065
-170
-8% -$3.33K
FSEP icon
6736
FT Vest US Equity Buffer ETF September
FSEP
$1.23B
$41K ﹤0.01%
+1,232
New +$40.1K
GYRE icon
6737
Gyre Therapeutics
GYRE
$714M
$41K ﹤0.01%
1,072
+289
+37% +$13.2K
HSDT icon
6738
Solana Company
HSDT
$98.1M
0
HYTR icon
6739
CP High Yield Trend ETF
HYTR
$290M
$41K ﹤0.01%
1,716
-385
-18% -$9.25K
INUV icon
6740
Inuvo
INUV
$16.8M
$41K ﹤0.01%
4,060
+3,854
+1,871% +$46.6K
SVRA icon
6741
Savara
SVRA
$1.19B
$41K ﹤0.01%
19,893
-3,686
-16% -$6.31K
WBIF icon
6742
WBI BullBear Value 3000 ETF
WBIF
$23.3M
$41K ﹤0.01%
1,360
-3,065
-69% -$88.6K
YCS icon
6743
ProShares UltraShort Yen
YCS
$29.6M
$41K ﹤0.01%
2,112
+1,028
+95% +$18.4K
YINN icon
6744
Direxion Daily FTSE China Bull 3X ETF
YINN
$732M
$41K ﹤0.01%
105
+88
+518% +$42.6K
FSCS
6745
First Trust SMID Capital Strength ETF
FSCS
$59.2M
$41K ﹤0.01%
1,480
+337
+29% +$8.87K
TLIS
6746
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$41K ﹤0.01%
+214
New +$53.4K
NGE
6747
DELISTED
Global X MSCI Nigeria ETF
NGE
$41K ﹤0.01%
3,418
+778
+29% +$9.49K
QFTA.U
6748
DELISTED
Quantum FinTech Acquisition Corporation Units, each consisting of one share of Common Stock and one Warrant
QFTA.U
$41K ﹤0.01%
+4,126
New +$41.8K
BWAC
6749
DELISTED
BETTER WORLD ACQUISITION CORP. Common Stock
BWAC
$41K ﹤0.01%
4,157
+4,107
+8,214% +$42.2K
RESN
6750
DELISTED
Resonant Inc.
RESN
$41K ﹤0.01%
9,633
+1,224
+15% +$6.58K

Similar funds

UBS Group's Q1 2021 Portfolio in Review

As of Q1 2021, UBS Group held 9,997 positions worth $301B, up 1.9% from $296B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q1 2021 filing shows 1,505 new, 3,920 increased, 3,391 reduced and 881 closed positions. Its largest new stake was Ferguson: 1,602,252 shares worth $192M. The largest sale was Stellantis, an estimated $937M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Financials.

  • UBS Group's largest Q1 2021 buy was Ferguson: 1,602,252 shares worth $192M.
  • UBS Group added most to Alibaba in Q1 2021, an estimated $2.76B increase.
  • UBS Group's biggest Q1 2021 reduction was Stellantis, cutting an estimated $937M.
  • UBS Group fully exited Tiffany & Co. in Q1 2021, selling an estimated $77.2M.
  • UBS Group's ten largest holdings make up 14% of its $301B portfolio in Q1 2021.
  • UBS Group opened 1,505 new positions and closed 881 in Q1 2021.
  • UBS Group's portfolio value rose 1.9% quarter-over-quarter to $301B.

Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.